Extracorporeal Membrane Oxygenation for Respiratory Failure

Anesthesiology
Michael QuintelLuciano Gattinoni

Abstract

This review focuses on the use of veno-venous extracorporeal membrane oxygenation for respiratory failure across all blood flow ranges. Starting with a short overview of historical development, aspects of the physiology of gas exchange (i.e., oxygenation and decarboxylation) during extracorporeal circulation are discussed. The mechanisms of phenomena such as recirculation and shunt playing an important role in daily clinical practice are explained.Treatment of refractory and symptomatic hypoxemic respiratory failure (e.g., acute respiratory distress syndrome [ARDS]) currently represents the main indication for high-flow veno-venous-extracorporeal membrane oxygenation. On the other hand, lower-flow extracorporeal carbon dioxide removal might potentially help to avoid or attenuate ventilator-induced lung injury by allowing reduction of the energy load (i.e., driving pressure, mechanical power) transmitted to the lungs during mechanical ventilation or spontaneous ventilation. In the latter context, extracorporeal carbon dioxide removal plays an emerging role in the treatment of chronic obstructive pulmonary disease patients during acute exacerbations. Both applications of extracorporeal lung support raise important ethical conside...Continue Reading

References

Feb 1, 1977·Anesthesiology·T KolobowJ E Pierce
Jan 1, 1977·Transactions - American Society for Artificial Internal Organs·T KolobowG Iapichino
Jan 1, 1992·Intensive Care Medicine·B Lachmann
Aug 15, 1986·JAMA : the Journal of the American Medical Association·L GattinoniA Agostoni
Sep 1, 1987·The American Review of Respiratory Disease·L GattinoniM Bombino
Jan 1, 1988·Journal of Applied Physiology·B E Marshall, C Marshall
Mar 23, 1972·The New England Journal of Medicine·W M Zapol, R J Kitz
Aug 22, 1966·JAMA : the Journal of the American Medical Association·J H Kennedy
Dec 8, 2000·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·H T TevaearaiL K von Segesser
Aug 3, 2001·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·A F van HeijstM van de Bor
Jan 1, 1957·Medical History·S T ANNING
Aug 19, 1965·The New England Journal of Medicine·H PONTOPPIDANE P RADFORD
Sep 14, 2004·Pediatric Cardiology·J Rychik
Apr 7, 2005·Intensive Care Medicine·Luciano Gattinoni, Antonio Pesenti
Feb 21, 2006·Clinical and Experimental Pharmacology & Physiology·Stuart B Hooper, Megan J Wallace
Mar 28, 2006·Thorax·D E O'Donnell, C M Parker
Jul 27, 2006·Expert Review of Medical Devices·Brittany A ZwischenbergerJoseph B Zwischenberger
Apr 17, 2007·Biomaterials·Joel L KaarWilliam J Federspiel
Apr 25, 2007·Critical Care Medicine·Alain Rudiger, Mervyn Singer
Sep 25, 2007·The Annals of Thoracic Surgery·Hitoshi SatoKeith E Cook
Dec 20, 2007·Critical Care Medicine·Massimo CressoniLuciano Gattinoni
Jun 1, 1949·Journal of Applied Physiology·R L RILEY, A COURNAND
Mar 22, 2008·The Annals of Thoracic Surgery·Christof SchmidFranz-Xaver Schmid
Sep 17, 2008·Intensive Care Medicine·Stéphanie RuizLila Bouadma
Jan 9, 2009·The New England Journal of Medicine·Michael P W GrocottUNKNOWN Caudwell Xtreme Everest Research Group
Feb 17, 2009·The Journal of Antimicrobial Chemotherapy·Isabel SprietLudo Willems
Mar 14, 2009·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Daniele CamboniChristof Schmid
Apr 7, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M StrueberS Keshavjee
Jun 17, 2009·Intensive Care Medicine·Alberto ZanellaAntonio Pesenti
Oct 14, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza InvestigatorsMarc Ziegenfuss
Oct 7, 2011·JAMA : the Journal of the American Medical Association·Moronke A NoahKathryn M Rowan
Oct 22, 2011·American Journal of Respiratory and Critical Care Medicine·Divay ChandraFernando Holguín
Apr 24, 2012·Journal of Critical Care·Kiran ShekarJason A Roberts

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Clinical Trials Mentioned

NCT02282657

Software Mentioned

ELSO
EOLIA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.